title: [Treatment of cluster headache].
abstract: Remarkable therapeutic improvements have come forward recently for trigemino-autonomic cephalalgias. Attack treatment in cluster headache is based on sumatriptan and oxygen. Non-vasoconstrictive treatments are opening a new post-triptan era but are not yet applicable. Prophylactic treatment of cluster headache is based on verapamil and lithium. The efficacy of anti-epileptic drugs in cluster headache remains to be demonstrated. Surgical treatment aimed at the parasympathetic pathways and at the trigeminal nerve demonstrates a high rate of recurrence and adverse events and questions about the relevance of a "peripheral" target in cluster headache. The efficacy of continuous hypothalamic stimulation in patients with intractable headache constitutes a breakthrough, but must be demonstrated at a larger scale and the benefice/risk ratio must be carefully evaluated. Indomethacin still remains the gold standard in paroxysmal hemicrania treatment. Until recently SUNCT was considered an intractable condition. However there are some reports of complete relief with lamotrigine, topiramate and gabapentin.
authors.affiliation: Service de Neurologie, Hôpital Rangueil, Toulouse, France.
authors.forename: N
authors.initials: N
authors.lastname: Fabre
mesh_terms: D003027:Cluster Headache / Q000628:therapy*; D005157:Facial Pain / Q000209:etiology; D006261:Headache / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D010102:Oxygen Inhalation Therapy; D018170:Sumatriptan / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000150:complications / Q000188:drug therapy*; D014653:Vascular Headaches / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D014662:Vasoconstrictor Agents; D018170:Sumatriptan